These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7423252)

  • 1. [Determination of urothelial tumor growth rate in men by the Y-chromatin content].
    Anichkov NM; Zus' BA; Kiriunichev DS
    Sov Med; 1980; (9):113-5. PubMed ID: 7423252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Y-sex chromatin in the sperm of men with varicocele].
    Kincheva V; Stanislavov R; Protich M; Nalbanski B
    Akush Ginekol (Sofiia); 1977; 16(6):449-52. PubMed ID: 602997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Establishment of individual identity by Y chromatin].
    Fedorovtsev AL; Koroleva EI; Tishinova LA; Dontsov VV
    Sud Med Ekspert; 1981; 24(3):57. PubMed ID: 7292569
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of growth rate of human transitional cell tumors according to sex chromatin (Barr bodies) content.
    Anichkov NM; Zus BA
    J Urol; 1980 Oct; 124(4):458-60. PubMed ID: 7420585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal determination of sex in man].
    Slozina NM; Matveeva OF; Petrova NV
    Vopr Okhr Materin Det; 1977 Sep; 22(9):59-60. PubMed ID: 919391
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen receptors in TCC.
    Kirkali Z
    Urology; 1987 Jun; 29(6):674. PubMed ID: 3576904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histological study of chorion frondosum sections for prenatal sex determination in the 1st pregnancy trimester].
    Kirpátovszkájá NA; Báchárév VA; Kazy Z
    Orv Hetil; 1980 Dec; 121(50):3057-9. PubMed ID: 7194466
    [No Abstract]   [Full Text] [Related]  

  • 8. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup.
    Palou J; Piovesan LF; Huguet J; Salvador J; Vicente J; Villavicencio H
    J Urol; 2004 Jul; 172(1):66-9. PubMed ID: 15201739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex chromatin in oncomorphology].
    Golovin DI; Zus' BA
    Arkh Patol; 1981; 43(12):3-8. PubMed ID: 7034695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of transforming growth factor-alpha in patients with transitional cell carcinoma.
    Chow NH; Liu HS; Chang CJ; Chi YC; Tzai TS; Li EI; Lin JS
    Anticancer Res; 1998; 18(3B):2053-7. PubMed ID: 9677466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
    Moll R; Laufer J; Wu XR; Sun TT
    Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
    Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
    Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
    Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of Y chromosome and bloodstains].
    Ishizu H
    Nihon Rinsho; 1984 Oct; 42(10):2385-94. PubMed ID: 6394791
    [No Abstract]   [Full Text] [Related]  

  • 20. [The proportion of X and Y spermatozoa in the ejaculate and in the female genital tract under various conditions (proceedings)].
    Kaiser R; Broer KH; Citoler P
    Arch Gynakol; 1977 Jul; 224(1-4):435-7. PubMed ID: 579895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.